JW (CAYMAN) THERAPEUTICS CO. LTD
(HKEX: 2126)
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquartered in Shanghai, China.
3.080 -
+0.050
(+1.65%)
Range
2.950 - 3.100
(5.08%)
Open
3.010
Previous Close
3.030
Bid Price
3.060
Bid Volume
('000)
6.5
Ask Price
3.080
Ask Volume
('000)
25
Volume
('000)
954.5
Value
2,870,005
Remark
-
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
